Multi-site benchmark classification of major depressive disorder using machine learning on cortical and subcortical measures
- PMID: 38212349
- PMCID: PMC10784593
- DOI: 10.1038/s41598-023-47934-8
Multi-site benchmark classification of major depressive disorder using machine learning on cortical and subcortical measures
Abstract
Machine learning (ML) techniques have gained popularity in the neuroimaging field due to their potential for classifying neuropsychiatric disorders. However, the diagnostic predictive power of the existing algorithms has been limited by small sample sizes, lack of representativeness, data leakage, and/or overfitting. Here, we overcome these limitations with the largest multi-site sample size to date (N = 5365) to provide a generalizable ML classification benchmark of major depressive disorder (MDD) using shallow linear and non-linear models. Leveraging brain measures from standardized ENIGMA analysis pipelines in FreeSurfer, we were able to classify MDD versus healthy controls (HC) with a balanced accuracy of around 62%. But after harmonizing the data, e.g., using ComBat, the balanced accuracy dropped to approximately 52%. Accuracy results close to random chance levels were also observed in stratified groups according to age of onset, antidepressant use, number of episodes and sex. Future studies incorporating higher dimensional brain imaging/phenotype features, and/or using more advanced machine and deep learning methods may yield more encouraging prospects.
© 2024. The Author(s).
Conflict of interest statement
PMT and NJ received a research grant from Biogen, Inc., for research unrelated to this manuscript. HJG has received travel grants and speakers honoraria from Fresenius Medical Care, Neuraxpharm, Servier and Janssen Cilag as well as research funding from Fresenius Medical Care unrelated to this manuscript. JCS has served as a consultant for Pfizer,Sunovion, Sanofi, Johnson & Johnson, Livanova, and Boehringer Ingelheim. The remaining authors declare no conflict of interest.
Figures
References
-
- Cleare AFSWCDKMBMLPAJ. A multidimensional tool to quantify treatment resistance in depression: The Maudsley staging method. J. Clin. Psychiatry. 2009;70:12363. - PubMed
MeSH terms
Grants and funding
- R37 MH101495/MH/NIMH NIH HHS/United States
- P41 RR008079/RR/NCRR NIH HHS/United States
- R01 HD050735/HD/NICHD NIH HHS/United States
- R01 CA193522/CA/NCI NIH HHS/United States
- K23 MH090421/MH/NIMH NIH HHS/United States
- MR/L010305/1/MRC_/Medical Research Council/United Kingdom
- R01 MH129832/MH/NIMH NIH HHS/United States
- R01 MH085734/MH/NIMH NIH HHS/United States
- ZIA MH002857/ImNIH/Intramural NIH HHS/United States
- P30 CA016672/CA/NCI NIH HHS/United States
- R01 MH116147/MH/NIMH NIH HHS/United States
- G0802594/MRC_/Medical Research Council/United Kingdom
- U54 EB020403/EB/NIBIB NIH HHS/United States
- R01 MH117601/MH/NIMH NIH HHS/United States
- K01 MH117442/MH/NIMH NIH HHS/United States
- R01 NS073939/NS/NINDS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Miscellaneous
